AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Change-To-Inventory" stands at -337.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
AbbVie Inc's third quarter result of 2.00 Million USD for the item "Change To Inventory" represents an increase of 103.57 percent compared to it's second quarter result.
Also, AbbVie Inc's third quarter result of 2.00 Million USD for the item "Change To Inventory" represents an increase of 103.12 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of -337.00 Million USD for the item "Change To Inventory" represents an increase of 16.38 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -242.00 Million United States Dollars compared to the value the year prior.
The 1 year change is -242.00 Million United States Dollars.
The 3 year change is 291.00 Million United States Dollars.
The 5 year change is -314.00 Million United States Dollars.
The 10 year change is 332.00 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change To Inventory | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change To Inventory | 486,508,953,600.00 |
![]() | Roche Holding AG - Change To Inventory | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change To Inventory | 280,205,508,085.11 |
![]() | Novartis AG - Change To Inventory | 255,096,620,580.91 |